In This Article:
Some Hester Biosciences Limited (NSE:HESTERBIO) shareholders may be a little concerned to see that insider Madhuri Kapadia recently sold a whopping ₹56m worth of stock at a price of ₹1,861 per share. That's a big dump, and it decreased their holding size by 13%, which is notable but not too bad.
See our latest analysis for Hester Biosciences
The Last 12 Months Of Insider Transactions At Hester Biosciences
Notably, that recent sale by insider Madhuri Kapadia was not the only time they sold Hester Biosciences shares this year. They previously made an even bigger sale of -₹55.5m worth of shares at a price of ₹1,861 per share. So what is clear is that an insider saw fit to sell at around the current price of ₹1,741. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. In this case, the big sale took place at around the current price, so it's not too bad (but it's still not a positive).
The chart below shows insider transactions (by individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
I will like Hester Biosciences better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.
Insider Ownership
For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. It's great to see that Hester Biosciences insiders own 61% of the company, worth about ₹8.9b. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.
So What Does This Data Suggest About Hester Biosciences Insiders?
An insider sold stock recently, but they haven't been buying. And even if we look to the last year, we didn't see any purchases. But it is good to see that Hester Biosciences is growing earnings. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. Therefore, you should should definitely take a look at this FREE report showing analyst forecasts for Hester Biosciences.
Of course Hester Biosciences may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.